GSK vs. NGG
Compare and contrast key facts about GlaxoSmithKline plc (GSK) and National Grid plc (NGG).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: GSK or NGG.
Correlation
The correlation between GSK and NGG is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
GSK vs. NGG - Performance Comparison
Key characteristics
GSK:
-0.38
NGG:
0.26
GSK:
-0.39
NGG:
0.48
GSK:
0.95
NGG:
1.08
GSK:
-0.32
NGG:
0.31
GSK:
-0.61
NGG:
0.72
GSK:
14.80%
NGG:
8.90%
GSK:
24.01%
NGG:
24.44%
GSK:
-54.70%
NGG:
-54.85%
GSK:
-18.50%
NGG:
-11.99%
Fundamentals
GSK:
$74.57B
NGG:
$59.71B
GSK:
$1.57
NGG:
$2.58
GSK:
23.27
NGG:
23.66
GSK:
0.77
NGG:
1.83
GSK:
$23.26B
NGG:
$11.36B
GSK:
$16.84B
NGG:
$3.56B
GSK:
$6.82B
NGG:
$4.26B
Returns By Period
In the year-to-date period, GSK achieves a 8.04% return, which is significantly higher than NGG's 2.71% return. Both investments have delivered pretty close results over the past 10 years, with GSK having a 5.43% annualized return and NGG not far behind at 5.27%.
GSK
8.04%
9.30%
-11.69%
-9.58%
5.78%
5.43%
NGG
2.71%
2.52%
-4.96%
3.36%
4.19%
5.27%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
GSK vs. NGG — Risk-Adjusted Performance Rank
GSK
NGG
GSK vs. NGG - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for GlaxoSmithKline plc (GSK) and National Grid plc (NGG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
GSK vs. NGG - Dividend Comparison
GSK's dividend yield for the trailing twelve months is around 4.26%, less than NGG's 11.50% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GSK GlaxoSmithKline plc | 4.26% | 4.60% | 3.75% | 4.78% | 6.14% | 6.86% | 5.34% | 6.93% | 7.13% | 8.82% | 7.43% | 7.60% |
NGG National Grid plc | 11.50% | 11.81% | 5.20% | 5.13% | 4.71% | 5.29% | 4.90% | 6.44% | 24.15% | 5.07% | 4.73% | 7.86% |
Drawdowns
GSK vs. NGG - Drawdown Comparison
The maximum GSK drawdown since its inception was -54.70%, roughly equal to the maximum NGG drawdown of -54.85%. Use the drawdown chart below to compare losses from any high point for GSK and NGG. For additional features, visit the drawdowns tool.
Volatility
GSK vs. NGG - Volatility Comparison
GlaxoSmithKline plc (GSK) has a higher volatility of 10.26% compared to National Grid plc (NGG) at 6.32%. This indicates that GSK's price experiences larger fluctuations and is considered to be riskier than NGG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
GSK vs. NGG - Financials Comparison
This section allows you to compare key financial metrics between GlaxoSmithKline plc and National Grid plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities